WHO Urges Rollout Of First Long-Acting HIV Prevention Jab
WHO urges immediate rollout of injectable lenacapavir (LEN) as a highly effective, long-acting HIV prevention alternative, especially with stagnating prevention efforts. They also advise using rapid testing kits for easier access. Despite funding cuts, WHO emphasizes implementing recommendations grounded in equity. In 2024, 1.3 million contracted HIV, mainly impacting sex workers, MSM, and transgender individuals.
